Comments on "Importance of Normalization of CA19-9 Levels After Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer''

被引：0
|
作者：
Xu, Hua-Xiang [1 ,2 ,3 ,4 ]
Li, Shuo [1 ,2 ,3 ]
Xu, Shuai-Shuai [1 ,2 ,3 ,4 ]
Liu, Liang [1 ,2 ,3 ,4 ]
Yu, Xian-Jun [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
来源：
ANNALS OF SURGERY | 2021年 / 274卷 / 06期
关键词：
RESECTION;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E800 / E801
页数：2
相关论文
共 50 条
  • [1] Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
    Tsai, Susan
    George, Ben
    Wittmann, David
    Ritch, Paul S.
    Krepline, Ashley N.
    Aldakkak, Mohammed
    Barnes, Chad A.
    Christians, Kathleen K.
    Dua, Kulwinder
    Griffin, Michael
    Hagen, Catherine
    Hall, William A.
    Erickson, Beth A.
    Evans, Douglas B.
    ANNALS OF SURGERY, 2020, 271 (04) : 740 - 747
  • [2] Importance of preoperative CA 19-9 Levels in Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy
    Tsai, S.
    Krepline, A.
    Aldakkak, M.
    Ritch, P. S.
    Erickson, B. A.
    Johnston, F.
    Christians, K. K.
    Evans, D. B.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S21 - S21
  • [3] Multimodality Neoadjuvant Therapy Increases Normalization of Carbohydrate Antigen 19-9 (CA19-9) in Patients with Pancreatic Cancer
    Krepline, A.
    Clarke, C. N.
    Christians, K.
    Ritch, P.
    George, B.
    Khan, A.
    Kulkarni, N.
    Hagen, C.
    Erickson, B.
    Hall, W.
    Aldakkak, M.
    Evans, D.
    Tsai, S.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S151 - S152
  • [4] Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels
    Ono, Yoshihiro
    Inoue, Yosuke
    Ito, Hiromichi
    Sasaki, Takashi
    Takeda, Tsuyoshi
    Ozaka, Masato
    Sasahira, Naoki
    Hiratsuka, Makiko
    Matsueda, Kiyoshi
    Oba, Atsushi
    Sato, Takafumi
    Saiura, Akio
    Takahashi, Yu
    HPB, 2023, 25 (01) : 100 - 108
  • [5] The Clinical Impact of CA19-9 Normalization Following Neoadjuvant Therapy in Pancreatic Cancer: A Multi-Institutional Study
    Hammad, A. Y.
    AlMasri, S. S.
    Paniccia, A.
    Lee, K. K.
    Bahary, N.
    Desilva, A. L.
    Aldakkak, M.
    Evans, D. B.
    Tsai, S.
    Zureikat, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S21 - S21
  • [6] The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis
    Chen Ye
    Abuduhaibaier Sadula
    Siqian Ren
    Xin Guo
    Meng Yuan
    Chunhui Yuan
    Dianrong Xiu
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 731 - 740
  • [7] The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis
    Ye, Chen
    Sadula, Abuduhaibaier
    Ren, Siqian
    Guo, Xin
    Yuan, Meng
    Yuan, Chunhui
    Xiu, Dianrong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (06) : 731 - 740
  • [8] Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma
    Newhook, Timothy E.
    Vreeland, Timothy J.
    Griffin, James F.
    Tidwell, Rebecca S.
    Prakash, Laura R.
    Koay, Eugene J.
    Ludmir, Ethan B.
    Smaglo, Brandon G.
    Pant, Shubham
    Overman, Michael
    Wolff, Robert A.
    Ikoma, Naruhiko
    Maxwell, Jessica
    Kim, Michael P.
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    ANNALS OF SURGERY, 2023, 277 (03) : 484 - 490
  • [9] Association of decline in serum Ca19-9 after neoadjuvant therapy with improved survival among borderline resectable pancreatic cancer patients
    Tsai, Susan
    Mahmoud, Anna
    George, Ben
    Kelly, Tracy R.
    Ritch, Paul S.
    Erickson, Beth
    Evans, Douglas B.
    Christians, Kathleen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] An evaluation of the diagnostic value of CA19-9 and CEA levels in patients with pancreatic cancer
    Zhenhua Ma
    The Journal of Biomedical Research, 2009, (03) : 199 - 202
12345